Central Venous Catheter Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation

Central Venous Catheter Market Analysis | CMI


Read here the latest updates on the Central Venous Catheter Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:1
Date added: 14 September 2020
Slides: 17
Provided by: Shweta2707
Category: Other


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Central Venous Catheter Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

  • Central Venous Catheter Market, By Product Type
    (Tunneled Catheters, Non-Tunneled Catheters), By
    Property (Anti-Microbial Catheter, Non-
    Anti-Microbial Catheter), By Design (Single
    Lumen, Double Lumen, Multi Lumen), By Composition
    (Polyurethane, Polyurethane/Polycarbonate,
    Silicone), By End User (Hospitals, Ambulatory
    Surgical Centers, Speciality Clinics Others),
    and By Region (North America, Latin America,
    Europe, Asia Pacific, Middle East Africa) -
    Size, Share, Outlook, and Opportunity Analysis,
    2019 - 2027
  • The global central venous catheter market is
    estimated to account for US 778.0 Mn in terms of
    value in 2019 and is expected to reach US
    1,164.5 Mn by the end of 2027.

Global Central Venous Catheter Market Drivers
  • Increasing prevalence of diseases that require
    long-term therapies such as cancer (chemotherapy)
    and end stage renal disease (dialysis) is
    expected to fuel growth of the U.S. Central
    Venous Catheter Market. For instance, according
    to the World Health Organization, around 18.1
    million new cases and 9.6 million deaths were
    registered due to cancer worldwide in 2018.
  • Moreover, high incidence of renal diseases is
    also expected to aid in the market growth. For
    instance, according to European Renal Association
    European Dialysis and Transplant Associations
    data in 2018, over 850 million people worldwide
    have some form of kidney disease.

  • Asia Pacific region held dominant position in the
    global central venous catheter market in 2018,
    accounting for 30.1 share in terms of value,
    followed by North America.

Global Central Venous Catheter Market Restraints
  • High cost of antimicrobial-coated catheters is
    expected to hinder growth of the global central
    venous catheter market. The average cost of an
    antimicrobial coated catheter is four times more
    than the cost of normal catheters without
    coating. This may lead to high preference for
    non-antimicrobial coated catheters to minimize
    the cost of surgery.
  • Moreover, there are significant risks and
    complications associated with central venous
    catheterization procedures such as bleeding,
    damage to blood vessel, arterial puncture,
    hematoma, and pneumothorax. Use of central venous
    catheters can also lead to infection at the
    insertion site of the catheter, contamination of
    the catheter, and haematogenous seeding of the
    catheter. This in turn is expected to hinder
    growth of the market.

Global Central Venous Catheter Market
  • Introduction of catheters with antimicrobial
    protection is expected to offer lucrative growth
    opportunities for players in the global central
    venous catheters market. For instance, in July
    2019, researchers from Nottingham University
    reported development of a Bactigon, a new family
    of biomaterials that have a major impact against
    antimicrobial resistance (AMR).
  • Major regulatory bodies are focused on offering
    guidance for product approval, which is expected
    to offer lucrative growth opportunities for
    players in the market. For instance, in January
    2020, the U.S. FDA released draft guidance
    detailing the information device-makers should
    include in 510(k) submissions of catheter-based
    devices intended to treat peripheral vasculature
  • Product type segment in the global central venous
    catheter market is estimated to be valued at US
    778.0 Mn in 2019 and is expected to reach US
    1,164.5 Mn by 2026 at a CAGR of 5.1 during the
    forecast period.

Market Trends/Key Takeaways
  • The use of evidence-based care bundles reinforced
    by real-time feedback has led to significant
    decrease in rate of catheter-related bloodstream
    infection in the intensive care unit. This in
    turn is expected to aid in growth of the market.
  • The use of central venous catheter in
    administering chemotherapy drugs has increased
    significantly. This is owing to various benefits
    of central venous catheters such it helps to
    avoid serious damage to skin and muscle tissue
    from drugs that are capable of such adverse
    effects if they leak outside a vein.

  • U.S.
  • The U.S. FDA authorized use of mono, duo, trio,
    Quattro lumen central venous catheters, as they
    fall under class II
  • Therefore, companies do not require a premarket
    approval before commercializing the device for
    central access procedures. However, a 510K
    approval is still necessary
  • According to the Federal Food, Drug and Cosmetic
    Act (Act), central venous catheters comes under
    class II and do not require approval i.e.
    premarket approval application (PMA). However the
    device is marketed under general controls
    provisions of the Act. which includes
    requirements for annual registration, listing of
    devices, good manufacturing practice, labeling
    and prohibitions against misbranding and

Value Chain Analysis
(No Transcript)
Global Central Venous Catheter Market
Competitive Landscape
  • Major players operating in the global central
    venous catheter market include, AngioDynamics,
    C.R. Bard, Teleflex Incorporated, B. Braun
    Melsungen AG, Kimal, Comed B.V., Medtronic Plc.,
    Smiths Medical, Inc., and Vygon Group.

Global Central Venous Catheter Market Key
  • Major players in the market are focused on
    adopting MA strategies to expand their product
    portfolio. For instance, in October 2019, Vygon
    Group acquired Pilot, an Italy-based ECG central
    venous catheter tip location and navigation
    devices manufacturer.
  • Major players in the market are also focused on
    adopting various marketing strategies to enhance
    their market share. For instance, in November
    2019, Teleflex Incorporated showcased its
    Interventional product portfolio including the
    MANTA Vascular Closure Device and Langston Dual
    Lumen Catheters at the PCR London Valves held in

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//www.coherentmarketinsights.com

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com